Praxis Precision Medicines, Inc.
corporate_fare Company Profile
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 23 items for PRAX at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Praxis Precision Medicines Secures $621.2M in Public Offering to Extend Cash Runway into 2028
- Praxis Precision Medicines Announces $575M Common Stock Offering at Discounted Price
- Praxis Precision Medicines Reports Strong $925M Cash Position
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$0
Net Income
-$303.27M
Diluted EPS
-$13.48
Op. Cash Flow
-$249.07M
Free Cash Flow
-$249.12M
Operating Income
-$326.2M
Cash & Equivalents
$357.33M
Debt / Equity
0.00×
Shares Outstanding
25.2M sh
Source: 10-K · filed 2026-02-19 · accession 0001689548-26-000029
show_chartPrice Chart
Loading chart...
feed PRAX - Filings & News (Page 2)
PRAX
Jan 07, 2026, 5:21 PM EST
Price at Filing:
$292.37
Real-time Price:
$275.00
Change:
-$17.37 (-6%)
Market Cap:
$8.397B
PRAX
Jan 07, 2026, 5:19 PM EST
Price at Filing:
$292.37
Real-time Price:
$275.00
Change:
-$17.37 (-6%)
Market Cap:
$8.397B
PRAX
Jan 06, 2026, 4:24 PM EST
Price at Filing:
$283.15
Real-time Price:
$275.00
Change:
-$8.15 (-3%)
Market Cap:
$8.397B